SAVASTANO, C.; LOMBARDI, F. Response to Lapatinib-Capecitabine combination in a young patient with recurrent HER2-positive breast cancer refractory to two lines of therapy with anti-HER2 drugs: Risposta alla combinazione Lapatinib-Capecitabina in giovane paziente con recidiva di carcinoma della mammella HER2-positivo refrattario a due linee di terapia con farmaci anti-HER2. AboutOpen, [S. l.], v. 4, n. 1, p. 162–165, 2018. DOI: 10.19156/abtpn.2018.0067. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/135. Acesso em: 3 jul. 2024.